Global Glucagon Like Peptide-1 (GLP-1) Agonists Market Survey and Trend Research 2018

ReportPage
Report ID
1431
Published Date
09-Dec
No of Report Page
89
Report Category
Editor's Rating
US $5,200.00
US $5,200.00
US $2,600.00

  • Report Details

    Summary
    Glucagon like peptide-1 (GLP-1) agonists is the agonists of the GLP-1 receptor. This class of drugs is used for the treatment of type 2 diabetes. One of their advantages is over older insulin secretagogues, such as sulfonylureas or meglitinides, and they have a lower risk of causing hypoglycemia.
    This report describes the development of the industry by upstream & downstream, industry overa

    More...
  • Table Of Content

    Table of Content
    Part 1 Industry Overview
    1.1 Glucagon Like Peptide-1 (GLP-1) Agonists Industry
    1.1.1 Definition
    1.1.2 Industry Trend
    1.2 Industry Chain
    1.2.1 Upstream
    1.2.2 Technology
    1.2.3 Cost Structure
    1.2.4 Consumer Preference
    1.2.2 Downstream
    Part 2 Industry Overall
    2.1 Industry History
    2.2 Development Prospect
    2.3 C

    More...
  • Inquiry Before Buying
    Inquiry Before Buying -
  • Request Sample
    Request For Sample